For laboratory research use onlyNot for human or animal consumption

Lyophilized Peptides

Tirzepatide Research Reference — 30 mg

Catalog material presented by identity, format, availability and applicable lot documentation for qualified laboratory procurement.

CatalogGT-PW-30MG
SourceSee lot documentation
FormatLyophilized Peptides
StatusAvailable
$210.00 Current catalog price; lot availability controls fulfillment.
AvailabilityIn stock

7451 in stock

Current product record, labeling and lot documentation control intended use and handling.

01Lot documentationCOA and analytical-record model
02Defined specificationMethod and result remain lot specific
03Tracked fulfillmentShipping method and lot allocation confirmed at order review
04Responsible useNon-clinical laboratory context

Lot documentation

Current Certificate of Analysis

4 approved certificates are attached to this product record.

Certificate of Analysis for Tirzepatide Research Reference — 30 mg, lot GT30-072026-1
Reported 2026-07-10Lot GT30-072026-199.89% purity
Open COA
Reported 2026-06-07Lot GT30-AS-062026-499.95% purity · 33.43 mg
Open COA
Reported 2026-03-22Lot GT30-032026-499.62% purity · 32.22 mg
Open COA
Reported 2025-10-11Lot TIR3010032025-1899.987% purity
Open COA

Technical information

Record at a glance

Primary catalog
Lyophilized Peptides
Product type
Simple product
Availability
Available
Lot control
Current lot documentation and approved product record control
Catalog number
GT-PW-30MG

Intended laboratory context

Illustrative applications

  • Evaluation within the lawful context identified by the current product record
  • Lot-specific documentation review before procurement or laboratory use

Documentation package

Documentation

  • PDFCertificate of Analysis / lot recordSample
  • PDFProduct data or handling recordSample
  • PDFSupporting product media archiveSample
Responsible-use statement

Intended use, handling, storage and limitations are controlled by the current product record, labeling and applicable lot documentation. No dosing or medical guidance is provided.

Need a current record?

Documentation before decision-making.

Reference GT-PW-30MG and the applicable lot when contacting technical support. Published files support evaluation but do not replace the approved lot COA or material specification.

View documentation model